Email Updates

Search form

You are here

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
MTN-037 I Sunday, June 17, 2018 DAIDS United States of America Women, Men, Transgender PC-1005 gel Ongoing July 2019
MTN-041 Other Wednesday, May 9, 2018 Malawi, South Africa, Uganda, Zimbabwe Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing September 2018
MTN-043 Open Label Malawi, South Africa, Uganda, Zimbabwe Women Dapivirine Ring Planned
MTN-044/IPM 053 Open Label, I Sunday, June 17, 2018 United States of America Women Dapivirine-Levonorgestrel ring Ongoing July 2019
NNRTI Microbicide Gel I Monday, March 31, 2014 Population Council, USAID United States of America Women PC-1005 gel, HEC gel Completed March 2015
POWER Demo Project Wednesday, July 1, 2015 University of Washington ICRC, Carnegie Mellon University, DTHF, Harvard U., KEMRI, Massachusetts General Hospital, RTI, Wits RHI, USAID South Africa, Kenya Women Ongoing June 2020
Pre-exposure prevention of viral entry (PREVENT) Pre-clinical Saturday, January 11, 2014 NIH, NIAID United States of America GRFT March 2019
Project Gel I Thursday, March 6, 2014 CONRAD, NICHD, NIMH United States of America, Puerto Rico MSM 1% tenofovir gel, HEC gel Completed March 2014
RMP 02/MTN 006 I Wednesday, September 30, 2009 CONRAD, NIAID, MTN United States of America Women, Men 1% tenofovir gel, HEC gel, TDF Completed July 2010
Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women Open Label Friday, June 5, 2015 Auritec Pharmaceuticals United States of America TDF, TDF/FTC (Truvada), Maraviroc Completed December 2016

Pages